2006 BioWales conference emphasises the region's expanding bioscience sector
Around 300 delegates attended the 2006 BioWales conference and Biopartnering event, held just outside Cardiff on March 23 and 24. The event was organized by the Welsh Development Agency, a sponsored body of the Welsh Assembly government, and played host to a wide range of delegates from the UK, the USA and Australia from both business and academia.
The introduction to the event was made by WDA Chairman Sir Roger Jones, founder of Penn Pharmaceuticals, a Tredegar, South Wales-headquartered integrated product development and specialist production firm which announced the sale of its manufacturing division to Celgene early last year. During his address, Sir Roger said that the future of bioscience development in the region looked bright, adding that the establishment of the new L50.0 million ($60.1 million) Institute of Life Science by IBM and Swansea University would further develop Wales as center for bioscience excellence.
GE Healthcare CEO makes keynote speech
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze